Mirae Asset Healthcare Fund Direct Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 49.413 ↓ -1.04%
[as on 8 July, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Mirae Asset Healthcare Fund Direct Growth and its peers as on 8 July, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Mirae Asset Healthcare Fund Direct Growth 15.58% -1.04% 0.76% 4.32% 16.21% 15.16% 25.23% 15.77% 25.75%-
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -6.46% -2.16% -1.24% 4.06% 2.33% -8.24% 8.45% 13.75% 15.9% 14.39%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -4.66% -2.16% -0.91% 4.09% 2.89% -2.55% 10.21% 10.48% 12.83% 12.45%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 17.85% -1.13% 0.17% 6.12% 20.37% 14.1% 25.2% 17.36% 25.59% 14.72%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 1.63% -1.4% -2.15% 0.8% 7.67% -1.19% 17.38% 18.62% 18.94% 15.49%
SBI PSU Fund - DIRECT PLAN - GROWTH 0.08% -1.65% -2.54% -1.76% -2.19% 5.02% 26.54% 24.06% 19.63% 15.07%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns--- 8.32% 77.37% 27.95% -10.87% 36.86% 41.36% -2.65%

Discrete returns (monthly)

MonthSep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026
Returns -0.93% 1.89% -0.38% -0.71% -5.19% 7.4% -3.5% 6.96% 3.31% 5.37%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 15.55% 7.96%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.92% 0.01% (Arbitrage: 0.00%) 0.00% 0.00% 0.07%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.20%
Divi's Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.93%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.94%
JB Chemicals & Pharmaceuticals Ltd.JBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology6.88%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services6.15%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology5.06%
Aurobindo Pharma Ltd.AUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology4.32%
Dr. Reddy's Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.31%
Fortis Healthcare Ltd.FORTIS (INE061F01013)Healthcare Services3.73%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology3.56%
Aster DM Healthcare Ltd.ASTERDM (INE914M01019)Healthcare Services3.44%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.37%
IPCA Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.32%
Krishna Institute of Medical Sciences Ltd.KIMS (INE967H01025)Healthcare Services3.26%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.25%
Sai Life Sciences Ltd.SAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.03%
Onesource Specialty Pharma Ltd.ONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology2.91%
Eris Lifesciences Ltd.ERIS (INE406M01024)Pharmaceuticals & Biotechnology2.67%
Dr. Lal Path labs Ltd.LALPATHLAB (INE600L01024)Healthcare Services1.95%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.88%
Mankind Pharma Ltd.MANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.67%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.27%
Anthem Biosciences Ltd.ANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.25%
Narayana Hrudayalaya Ltd.NH (INE410P01011)Healthcare Services1.17%
Max Healthcare Institute Ltd.MAXHEALTH (INE027H01010)Healthcare Services1.11%
Rubicon Research Ltd.RUBICON (INE506V01022)Pharmaceuticals & Biotechnology0.85%
Sagility Ltd.SAGILITY (INE0W2G01015)IT - Services0.54%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology0.49%
Sudeep Pharma Ltd.SUDEEPPHRM (INE0QPI01025)Pharmaceuticals & Biotechnology0.44%
Deepak Nitrite Ltd.DEEPAKNTR (INE288B01029)Chemicals & Petrochemicals0.43%
Neogen Chemicals Ltd.NEOGEN (INE136S01016)Chemicals & Petrochemicals0.42%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology0.09%

Debt

NameRatingWeight %
Mirae Asset Liquid Fund-Direct Plan-Growth0.01%
Portfolio data is as on date 31 March, 2026

NAV history

Mirae Asset Healthcare Fund Direct Growth - 30 days NAV (Net asset value) history

DateNAV% change
8 July, 202649.413 -1.04%
7 July, 202649.932 -0.6%
6 July, 202650.233 0.24%
3 July, 202650.111 1.35%
2 July, 202649.443 0.83%
1 July, 202649.038 -0.47%
30 June, 202649.270 0.78%
29 June, 202648.887 0.73%
25 June, 202648.534 -0.05%
24 June, 202648.559 0.07%
23 June, 202648.526 0.48%
22 June, 202648.294 0.48%
19 June, 202648.061 0.83%
18 June, 202647.666 0.9%
17 June, 202647.240 0.02%
16 June, 202647.230 -0.32%
15 June, 202647.382 -0.76%
12 June, 202647.747 0.44%
11 June, 202647.536 0.28%
10 June, 202647.403 -0.7%
9 June, 202647.737 0.78%
8 June, 202647.369 0.04%
5 June, 202647.350 0.71%
4 June, 202647.016 0.45%
3 June, 202646.806 0.52%
2 June, 202646.563 -0.42%
1 June, 202646.761 -0.9%
29 May, 202647.185 -1.34%
27 May, 202647.827 0.11%
26 May, 202647.774

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
    The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 49.413 as on 8 July, 2026.
  • What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
    The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are 15.58% as on 8 July, 2026.
  • What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
    The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 15.16% as on 8 July, 2026.
  • What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 25.23% as on 8 July, 2026.
  • What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 15.77% as on 8 July, 2026.